News

The application processes to the national regulatory agencies and ethics committees have proceeded according to plan, and the company has now received agency approvals for a European Phase

At that time, Mr Kaminski will replace Bevil Hogg, who has served as the CEO since 1997 and will remain an active member of the company’s board of

Mr Drapeau will lead the day-to-day operations of the company while retaining his current CFO responsibilities. An active CEO search has been initiated. In addition, Evan Melrose has

Dr Berendt is currently a director of Waters Corporation and has served on the board of directors of numerous other life sciences companies. Dr Berendt has received a

Also, Alastair McEwan, chairman of the board of Cornerstone BioPharma, has been appointed to the board of directors of Cornerstone Therapeutics. Concurrently, Cornerstone Therapeutics also appointed three independent

Michael Boswell has been appointed to the board and will assume Mr MacLellan’s former role as chairman of AMDL’s audit committee and board member William Thompson will assume

Pursuant to the terms of the amicable agreement, Vyta now controls 100% ownership interest in Bioagra and Paul Metzinger, president and CEO of Vyta becomes the sole manager,

Impulse Monitoring (IMI) will provide St Vincent’s with comprehensive intraoperative neuromonitoring (IONM) services including IMI-qualified neurophysiologists and real-time professional oversight experienced physicians. IONM assesses neurological function involving the

Advinus will combine its services with AgilityBio’s imaging services that use BioImagene’s digital pathology solutions for cancer diagnosis and research. This partnership will bring about a synergy between